Gilteritinib
Category: CancerGilteritinib Overview
Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug.[6] It acts as an inhibitor of AXL receptor tyrosine kinase, hence it is a tyrosine kinase inhibitor.[7] It was developed by Astellas Pharma. In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia (AML).[8]...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gilteritinib
Recent Gilteritinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Gilteritinib
- Tablet: 40mg
Other drugs which contain Gilteritinib or a similar ingredient: (1 result)
- XOSPATA Gilteritinib